Skip to main content
. Author manuscript; available in PMC: 2011 Feb 17.
Published in final edited form as: ACS Chem Neurosci. 2010 Feb 17;1(2):95–103. doi: 10.1021/cn900024r

Figure 4. PB1 and PB2 exhibit greater protection than TCEP against METC disruption.

Figure 4

PB1 (100 μM) and PB2 (1 μM) significantly rescue RGC-5 cells to levels indistinguishable from control against menadione and antimycin A. TCEP does not result in significant protection against any of the METC-active compounds. ** (p<0.01).